PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
SOLV
Ticker

SOLV

Congressional Trades
9
by 5 members
Buys
2
22%
Sells
7
78%
Total Volume
$121K
midpoint
Unique Traders
5
members

Party Breakdown

Democrats5 · 56%
Republicans4 · 44%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCE

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
02
May '24
2
01
Jan '25
02
Feb '25
Dec '25
02
Democrats05Net sellers
vs
Republicans22Neutral
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-20$250K
    SOLVENTUM CORPORATION
    -Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10). -Healthcare Outcomes Act. -Issues related to the use of Artificial Intelligence. -Issues related to H.R. 1 implementation (One Big Beautiful Bill). -Issues rel
  • 2026-04-20$60K
    SOLVENTUM
    General issue monitoring related to medical, dental, and health information systems research and development. General issue monitoring related to trade and tariff policy, including Section 232 issues. General issue monitoring related to healthcare policy. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. Issues related to healthcare in the FY26 and FY27 Appropriations process. General issue monitoring related to Medicare and Medicaid policy. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. General issue monitoring related to medical, dental, and health information systems research and development.
  • 2026-01-20$60K
    SOLVENTUM
    General issue monitoring related to healthcare policy. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. Issues related to healthcare in the FY26 Appropriations process. General issue monitoring related to Medicare and Medicaid policy. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. General issue monitoring related to medical, dental, and health information systems research and development. General issue monitoring related to trade and tariff policy, including Section 232 issues. General issue monitoring related to medical, dental, and health information systems research and development.
  • 2025-10-20$140K
    SOLVENTUM CORPORATION
    Issues related to Veterans Administration and Veterans Health Administration policy, procurement, and contracting processes for medical technology. -Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10). -Healthca
  • 2025-10-20$60K
    SOLVENTUM CORPORATION
    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development. Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
  • 2025-10-20$60K
    SOLVENTUM
    General issue monitoring related to trade and tariff policy. General issue monitoring related to medical, dental, and health information systems research and development. General issue monitoring related to healthcare policy. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. Issues related to healthcare in the FY26 Appropriations process. General issue monitoring related to Medicare and Medicaid policy. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. General issue monitoring related to medical, dental, and health information systems research and development.
  • 2025-07-21$60K
    SOLVENTUM
    General issue monitoring related to trade and tariff policy. General issue monitoring related to medical, dental, and health information systems research and development. General issue monitoring related to healthcare policy. H.R.1 - One Big Beautiful Bill Act Issues related to healthcare in the FY26 Appropriations process. General issue monitoring related to Medicare and Medicaid policy. H.R.1 - One Big Beautiful Bill Act General issue monitoring related to medical, dental, and health information systems research and development.
  • 2025-04-21$330K
    SOLVENTUM CORPORATION
    -Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10). -Healthcare Outcomes Act. -Issues related to the use of Artificial Intelligence. -Issues related to tariffs. -FDA appropriations. -Medicare and Medicaid payment quality
  • 2025-04-20$60K
    SOLVENTUM CORPORATION
    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development. Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development. Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.

Congressional Momentum

buy vs. sell pressureDISTRIBUTING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
13
2 buys9 total7 sells
$16K buys · $105K sells
Cumulative Net Position (buy vol − sell vol)
-$89K
2024-059 trades plotted2025-12

Trade Activity Timeline

Congressional buys & sells by month · last 4 months w/ activity

24/05
25/01
25/02
25/12
BuysSellsOtherHigh-volume month

Who Moved First

each row = one member · sorted by earliest disclosed trade
1 buyers ·4 sellers
2025RTommy Tuberville2×2024-05-03 · buy · $8K2024-05-03 · buy · $8KDGary Peters2×2024-05-14 · sell · $8K2024-05-14 · sell · $8KDJulie Johnson1×2025-01-15 · sell · $8KDRon Wyden2×2025-02-06 · sell · $8K2025-02-06 · sell · $8KRJ. Hill2×2025-12-31 · sell · $33K2025-12-31 · sell · $33K
BuySellOtherDot size ∝ trade size · top 5 most-active traders shown

All Disclosed Trades

DateMemberActionAmountFiling Delay
2025-12-31RJ. HillSELL$15K – $50K26d
2025-12-31RJ. HillSELL$15K – $50K23d
2025-02-06DRon WydenSELL$1K – $15K15d
2025-02-06DRon WydenSELL$1K – $15K15d
2025-01-15DJulie JohnsonSELL$1K – $15K28d
2024-05-03RTommy TubervilleBUY$1K – $15K42d
2024-05-03RTommy TubervilleBUY$1K – $15K42d
2024-05-14DGary PetersSELL$1K – $15K10d
2024-05-14DGary PetersSELL$1K – $15K9d